Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
18.69
-0.37 (-1.94%)
Aug 12, 2025, 11:53 AM - Market open

Paramount Global Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
209.83169.8122.7889.19
Revenue Growth (YoY)
135.27%38.29%37.67%-
Cost of Revenue
76.9366.9252.8146.39
Gross Profit
132.9102.8869.9742.79
Selling, General & Admin
124.4110.61102.2388.97
Research & Development
36.8735.9233.7426.17
Operating Expenses
161.27146.53135.97115.14
Operating Income
-28.36-43.65-66-72.35
Interest Expense
-4.41-4.51-4.71-4.2
Interest & Investment Income
1.60.815.782.2
Other Non Operating Income (Expenses)
-1.060.22-1.051.83
EBT Excluding Unusual Items
-32.24-47.14-65.98-72.52
Other Unusual Items
---1.54-
Pretax Income
-32.24-47.14-67.51-72.52
Net Income
-32.24-47.14-67.51-72.52
Net Income to Common
-32.24-47.14-67.51-72.52
Shares Outstanding (Basic)
11877
Shares Outstanding (Diluted)
11877
Shares Change (YoY)
69.46%8.89%4.59%-
EPS (Basic)
-2.81-6.10-9.52-10.70
EPS (Diluted)
-2.81-6.10-9.52-10.70
Free Cash Flow
-19.54-34.78-50.15-69.7
Free Cash Flow Per Share
-1.70-4.50-7.07-10.28
Gross Margin
63.34%60.59%56.99%47.98%
Operating Margin
-13.52%-25.71%-53.75%-81.12%
Profit Margin
-15.36%-27.76%-54.98%-81.31%
Free Cash Flow Margin
-9.31%-20.48%-40.85%-78.15%
EBITDA
-23.17-38.85-61.55-68.02
EBITDA Margin
-11.04%-22.88%-50.13%-76.27%
D&A For EBITDA
5.194.84.454.33
EBIT
-28.36-43.65-66-72.35
EBIT Margin
-13.52%-25.71%-53.75%-81.12%
Revenue as Reported
209.83169.8122.7889.19
Advertising Expenses
-0.50.80.7
Updated May 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q